Literature DB >> 15907937

Structure of the RNA signal essential for translational frameshifting in HIV-1.

Cyril Gaudin1, Marie-Hélène Mazauric, Mounir Traïkia, Eric Guittet, Satoko Yoshizawa, Dominique Fourmy.   

Abstract

Many pathogenic viruses use a programmed -1 translational frameshifting mechanism to regulate synthesis of their structural and enzymatic proteins. Frameshifting is vital for viral replication. A slippery sequence bound at the ribosomal A and P sites as well as a downstream stimulatory RNA structure are essential for frameshifting. Conflicting data have been reported concerning the structure of the downstream RNA signal in human immunodeficiency virus type 1 (HIV-1). Here, the solution structure of the HIV-1 frameshifting RNA signal was solved by heteronuclear NMR spectroscopy. This structure reveals a long hairpin fold with an internal three-nucleotide bulge. The internal loop introduces a bend between the lower and upper helical regions, a structural feature often seen in frameshifting pseudoknots. The NMR structure correlates with chemical probing data. The upper stem rich in conserved G-C Watson-Crick base-pairs is highly stable, whereas the bulge region and the lower stem are more flexible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907937     DOI: 10.1016/j.jmb.2005.04.045

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  38 in total

Review 1.  Targeting frameshifting in the human immunodeficiency virus.

Authors:  Léa Brakier-Gingras; Johanie Charbonneau; Samuel E Butcher
Journal:  Expert Opin Ther Targets       Date:  2012-03       Impact factor: 6.902

2.  Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.

Authors:  Prakash B Palde; Leslie O Ofori; Peter C Gareiss; Jaclyn Lerea; Benjamin L Miller
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

3.  Identification of a cellular factor that modulates HIV-1 programmed ribosomal frameshifting.

Authors:  Yoshifumi Kobayashi; Jianling Zhuang; Stuart Peltz; Joseph Dougherty
Journal:  J Biol Chem       Date:  2010-04-23       Impact factor: 5.157

4.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

5.  Analyzing the flexibility of RNA structures by constraint counting.

Authors:  Simone Fulle; Holger Gohlke
Journal:  Biophys J       Date:  2008-02-15       Impact factor: 4.033

6.  Predicting ribosomal frameshifting efficiency.

Authors:  Song Cao; Shi-Jie Chen
Journal:  Phys Biol       Date:  2008-03-11       Impact factor: 2.583

7.  Structural and dynamic characterization of the upper part of the HIV-1 cTAR DNA hairpin.

Authors:  Loussiné Zargarian; Igor Kanevsky; Ali Bazzi; Jonathan Boynard; Françoise Chaminade; Philippe Fossé; Olivier Mauffret
Journal:  Nucleic Acids Res       Date:  2009-05-05       Impact factor: 16.971

Review 8.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

9.  Interaction of the HIV-1 frameshift signal with the ribosome.

Authors:  Marie-Hélène Mazauric; Yeonee Seol; Satoko Yoshizawa; Koen Visscher; Dominique Fourmy
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

10.  CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription.

Authors:  Anju Bansal; Jonathan Carlson; Jiyu Yan; Olusimidele T Akinsiku; Malinda Schaefer; Steffanie Sabbaj; Anne Bet; David N Levy; Sonya Heath; Jianming Tang; Richard A Kaslow; Bruce D Walker; Thumbi Ndung'u; Philip J Goulder; David Heckerman; Eric Hunter; Paul A Goepfert
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.